OKYO Pharma Limited Sponsored ADR OKYO

1.38 0.00 0.00% as of 25 Sep
Market cap
$72.4M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Mar '26 Sep '25 Mar '25 Sep '24 Older periods
ROE
0.00% 0.00% 0.00% 0.00%

+7 more TTM periods

ROA
0.00% 0.00% 0.00% 0.00%
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
0.00% 0.00% 0.00% 0.00%
Average Days of Receivables
0.00 0.00 0.00 0.00
Free Cash Flow per Share
0.00 0.00 0.00 0.00
Free Cash Flow
(9.53) (13.07) (19.25) (20.85)
Capital Expenditures
(0.01) — (0.01) —
Other line items
Cash ROIC
(28.90%) (1,319.14%) 482.28% 334.24%
Accounts Receivable Turnover
0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00
Operating CF/Net income
0.00 0.00 0.00 0.00
Depreciation/Fixed assets
0.43 7.17 1.10 4.77
Capex/Depreciation
(2.03) 0.00 (0.87) 0.00
Operating CF per Share
0.00 0.00 0.00 0.00
Capex per Share
0.00 — 0.00 —
Capex to Sales
0.00 — 0.00 —

Fold the line items

Columns are period end dates